| Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease DT Dexter, CJ Carter, FR Wells, F Javoy‐Agid, Y Agid, A Lees, P Jenner, ... Journal of neurochemistry 52 (2), 381-389, 1989 | 1842 | 1989 |
| Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats CJ Pycock, RW Kerwin, CJ Carter Nature 286 (5768), 74-77, 1980 | 678 | 1980 |
| Microbes and Alzheimer's disease RF Itzhaki, R Lathe, BJ Balin, MJ Ball, EL Bearer, H Braak, MJ Bullido, ... Handbook of Infection and Alzheimer's Disease, 3-8, 2017 | 558 | 2017 |
| Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity H Schoemaker, Y Claustre, D Fage, L Rouquier, K Chergui, O Curet, ... Journal of Pharmacology and Experimental Therapeutics 280 (1), 83-97, 1997 | 506 | 1997 |
| Fractalkine modulates TNF‐α secretion and neurotoxicity induced by microglial activation V Zujovic, J Benavides, X Vigé, C Carter, V Taupin Glia 29 (4), 305-315, 2000 | 443 | 2000 |
| Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase M Teufel, V Saudek, JP Ledig, A Bernhardt, S Boularand, A Carreau, ... Journal of Biological Chemistry 278 (8), 6521-6531, 2003 | 389 | 2003 |
| Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. B Gotti, D Duverger, J Bertin, C Carter, R Dupont, J Frost, B Gaudilliere, ... Journal of Pharmacology and Experimental Therapeutics 247 (3), 1211-1221, 1988 | 310 | 1988 |
| Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat CJ Carter, CJ Pycock Brain Research 192, 163-176, 1980 | 292 | 1980 |
| Effect of 6‐hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat CJ Pycock, CJ Carter, RW Kerwin Journal of neurochemistry 34 (1), 91-99, 1980 | 290 | 1980 |
| Aspirin and salicylate protect against MPTP‐induced dopamine depletion in mice N Aubin, O Curet, A Deffois, C Carter Journal of neurochemistry 71 (4), 1635-1642, 2002 | 284 | 2002 |
| Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. C Carter, J Benavides, P Legendre, JD Vincent, F Noel, F Thuret, ... Journal of Pharmacology and Experimental Therapeutics 247 (3), 1222-1232, 1988 | 260 | 1988 |
| Lipid peroxidation as cause of nigral cell death in Parkinson's disease DT Dexter, C Carter, F Agid, Y Agid, AJ Lees, P Jenner, CD Marsden The Lancet 328 (8507), 639-640, 1986 | 256 | 1986 |
| Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat R Dennis, T: l'Heureux, C Carter, S B J Pharmacol Exp Ther 241, 642-649, 1987 | 232 | 1987 |
| Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats CJ Carter Neuropharmacology 21 (5), 379-383, 1982 | 218 | 1982 |
| Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. CJ Carter, KG Lloyd, B Zivkovic, B Scatton Journal of Pharmacology and Experimental Therapeutics 253 (2), 475-482, 1990 | 217 | 1990 |
| Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study CJ Carter, R L'heureux, B Scatton Journal of neurochemistry 51 (2), 462-468, 1988 | 211 | 1988 |
| Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage J Benavides, D Fage, C Carter, B Scatton Brain research 421 (1-2), 167-172, 1987 | 209 | 1987 |
| lfenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor C Carter, JP Rivy, B Scatton Eur. J. Pharmacol 164 (3), 611-612, 1987 | 201 | 1987 |
| Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis CJ Carter Neurochemistry international 50 (1), 12-38, 2007 | 175 | 2007 |
| Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii CJ Carter Schizophrenia bulletin 35 (6), 1163-1182, 2009 | 172 | 2009 |
Marijan KlaricaProfesor farmakologije, Sveučilište u Zagrebu在 mef.hr 的电子邮件经过验证
